van den Beld et al. [45] reported that low serum Alb levels were closely related to high levels of insulin-like growth factor-binding protein 2 (IGFBP-2) and IL-6: other two independent poor prognosticators of GBM [46, 47]. Here, IL6 is linked to glioblastoma.